Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -1.41% | 131.11 | 0.0% | $2534.51m | |
| BNGO | BioNano Genomics, Inc. | 12.58% | 9.31 | 0.0% | $1903.04m | |
| GILD | Gilead Sciences, Inc. | 0.37% | 67.23 | 1.0% | $665.17m | |
| AMGN | Amgen, Inc. | 1.15% | 254.93 | 1.3% | $566.38m | |
| CRSP | CRISPR Therapeutics AG | 1.46% | 187.80 | 0.6% | $493.07m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.19% | 159.75 | 2.0% | $482.53m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.35% | 542.71 | 2.7% | $480.30m | |
| NVAX | Novavax, Inc. | 2.35% | 125.28 | 92.9% | $438.91m | |
| ILMN | Illumina, Inc. | 0.43% | 406.60 | 3.5% | $395.97m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.76% | 98.63 | 13.8% | $362.88m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.62% | 240.12 | 1.9% | $362.65m | |
| BIIB | Biogen, Inc. | -0.34% | 269.20 | 1.7% | $325.55m | |
| BNTX | BioNTech SE | 1.68% | 107.20 | 0.0% | $304.57m | |
| EXAS | EXACT Sciences Corp. | 1.34% | 150.05 | 19.6% | $243.09m | |
| PACB | Pacific Biosciences of California, Inc. | 2.09% | 37.07 | 7.4% | $235.63m |
Company Profile
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.